learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
Search
forLearn
1 / 1 resultsResearch
5 / 1000+ results
research What Happens When Simulations Get Real and Cosmetic Dermatology Goes Virtual?
AI and AR are improving cosmetic dermatology but face challenges like data quality and ethical concerns.
research Hydrogel Composites for Multifunctional Biomedical Applications
Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.
research Advancing Aesthetic Medicine Through Exosome-Based Regenerative Therapies With Dr. Face Innovations: Molecular Mechanisms, Nanotechnology Integration, And Data-Driven Insights
Exosome therapies improve skin, hair, and healing but face challenges like cost and regulation.
research Artificial Intelligence-Based Personalization of Treatment Regimen for Hair Loss: A 6-Month Clinical Trial
AI-personalized hair loss treatments improved hair growth and scalp health without side effects.
research The Metaverse: A New Frontier in the Management of Hair Loss and Nail Disorders
The metaverse offers potential for managing hair and nail disorders but faces challenges like technology limits and accessibility.
Community Join
5 / 358 resultscommunity Has anyone done research on Absci's AI‑driven antibody platform? Seeking your thoughts!
A user is interested in Absci's AI-driven antibody platform, ABS-201, for treating androgenetic alopecia, which shows promising preclinical results and potential for hair regrowth and pigmentation restoration. However, concerns are raised about the drug's development timeline and its advantages compared to existing treatments.
community We should actually be hopeful for these recent new developments
AI advancements, like AlphaFold, are speeding up drug discovery for hair loss, promising more effective treatments. Current options like minoxidil and finasteride have limitations, but new developments could improve solutions in 5-10 years.
community Petition: Make PP405 available tomorrow instead of 2030
PP405, a promising hair loss treatment, is expected to be available by 2027, with faster trials due to its topical nature. Users are eager for its release, comparing it to existing treatments like minoxidil and finasteride, but remain cautious about its long-term effectiveness.
community What product does David Dobrik use
David Dobrik uses Minoxidil and possibly Finasteride for hair loss but applies them incorrectly. Users suggest he consider surgery due to his financial capability.
community New warning by FDA on topical finasteride
The FDA warned that topical finasteride can cause serious side effects like sexual dysfunction and brain fog, similar to oral finasteride. Compounded topical formulations pose additional risks due to lack of regulation.